Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (151-160 of 299) with videos related to

Pageof 30
Sort By:
Haematologica|March 28, 2024
MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implicationsChengfeng Bi, Yuhua Huang, Roshia Ali, et al.
British Journal of Haematology|November 25, 2003
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's diseaseFrancis J Giles, Julie M Vose, Kim-Anh Do, et al.
Blood|April 4, 2008
ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma ProjectKerry J Savage, Nancy Lee Harris, Julie M Vose, et al.
Cancer|April 9, 2014
Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remissionSai Ravi Pingali, Sarah W Jewell, Luiza Havlat, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2003
Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphomaNicole Y Fang, Timothy C Greiner, Dennis D Weisenburger, et al.
Molecular Cancer Research : MCR|December 17, 2008
Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic targetGanapati V Hegde, Katie J Peterson, Katy Emanuel, et al.
Hematological Oncology|October 20, 2011
Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantationKeni Gu, Dennis D Weisenburger, Kai Fu, et al.
American Journal of Hematology|February 18, 2011
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter studyJorge J Castillo, Brady E Beltran, Michele Bibas, et al.
British Journal of Haematology|December 7, 2018
Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphomaJayadev M Umakanthan, Javeed Iqbal, Connie L Batlevi, et al.
British Journal of Haematology|April 5, 2014
Lymphoma diagnosis at an academic centre: rate of revision and impact on patient careJoslin M Bowen, Anamarija M Perry, Javier A Laurini, et al.
Pageof 30

Showing results (151-160 of 299) with videos related to

Sort By:
Pageof 30
Haematologica|March 28, 2024
MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implicationsChengfeng Bi, Yuhua Huang, Roshia Ali, et al.
British Journal of Haematology|November 25, 2003
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's diseaseFrancis J Giles, Julie M Vose, Kim-Anh Do, et al.
Blood|April 4, 2008
ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma ProjectKerry J Savage, Nancy Lee Harris, Julie M Vose, et al.
Cancer|April 9, 2014
Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remissionSai Ravi Pingali, Sarah W Jewell, Luiza Havlat, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2003
Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphomaNicole Y Fang, Timothy C Greiner, Dennis D Weisenburger, et al.
Molecular Cancer Research : MCR|December 17, 2008
Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic targetGanapati V Hegde, Katie J Peterson, Katy Emanuel, et al.
Hematological Oncology|October 20, 2011
Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantationKeni Gu, Dennis D Weisenburger, Kai Fu, et al.
American Journal of Hematology|February 18, 2011
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter studyJorge J Castillo, Brady E Beltran, Michele Bibas, et al.
British Journal of Haematology|December 7, 2018
Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphomaJayadev M Umakanthan, Javeed Iqbal, Connie L Batlevi, et al.
British Journal of Haematology|April 5, 2014
Lymphoma diagnosis at an academic centre: rate of revision and impact on patient careJoslin M Bowen, Anamarija M Perry, Javier A Laurini, et al.
Pageof 30